Delayed Graft Function in the Kidney Transplant

Acute kidney injury occurs with kidney transplantation and too frequently progresses to the clinical diagnosis of delayed graft function (DGF). Poor kidney function in the first week of graft life is detrimental to the longevity of the allograft. Challenges to understand the root cause of DGF include several pathologic contributors derived from the donor (ischemic injury, inflammatory signaling) and recipient (reperfusion injury, the innate immune response and the adaptive immune response). Progressive demand for renal allografts has generated new organ categories that continue to carry high risk for DGF for deceased donor organ transplantation. New therapies seek to subdue the inflammatory response in organs with high likelihood to benefit from intervention. Future success in suppressing the development of DGF will require a concerted effort to anticipate and treat tissue injury throughout the arc of the transplantation process.

[1]  R. Ploeg,et al.  Machine perfusion or cold storage in deceased-donor kidney transplantation. , 2009, The New England journal of medicine.

[2]  G. Gomes,et al.  TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720. , 2011, International immunopharmacology.

[3]  Anthony J. Muslin,et al.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. , 2011, Kidney international.

[4]  T. Minor,et al.  Single-Center Experience With Kidney Transplantation Using Deceased Donors Older Than 75 Years , 2011, Transplantation.

[5]  G. Klintmalm,et al.  YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study 1,2,3 , 2011, Clinical transplantation.

[6]  B. Winkens,et al.  Kidney Transplantation from Donors after Cardiac Death: Uncontrolled versus Controlled Donation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  H. van Goor,et al.  Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Jean‐Paul Squifflet,et al.  Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  P. Reese,et al.  Recipient Risk Factors Associated With Delayed Graft Function: A Paired Kidney Analysis , 2011, Transplantation.

[10]  D. Goldfarb A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. , 2011, The Journal of urology.

[11]  F. Schena,et al.  T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[12]  A. Layton,et al.  A mathematical model of the myogenic response to systolic pressure in the afferent arteriole. , 2011, American journal of physiology. Renal physiology.

[13]  J. Vella,et al.  Hypertension after kidney transplant. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  K. Hruska,et al.  RGS4 Prevents the Development of Renal Dysfunction in Response to Ischemia/Reperfusion Injury , 2011 .

[15]  B. Banas,et al.  A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. , 2010, Clinical science.

[16]  E. Hajizadeh,et al.  Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction. , 2010, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[17]  M. Christiaans,et al.  Kidney Transplantation From Donors After Cardiac Death: A 25-Year Experience , 2010, Transplantation.

[18]  A. Pascher,et al.  Novel Markers in Zero-Hour Kidney Biopsies Indicate Graft Quality and Clinical Outcome , 2010, Transplantation.

[19]  J. Pratschke,et al.  Role of heme oxygenase‐1 in transplantation , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[20]  D. Kuypers,et al.  A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients. , 2010, Clinical therapeutics.

[21]  A Buscaroli,et al.  The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience. , 2010, Transplantation proceedings.

[22]  L. Domański,et al.  Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function. , 2010, Journal of the American College of Surgeons.

[23]  L. Otterbein,et al.  Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  Jean-Paul Squifflet,et al.  Machine Perfusion Versus Cold Storage for the Preservation of Kidneys Donated After Cardiac Death: A Multicenter, Randomized, Controlled Trial , 2010, Annals of surgery.

[25]  Rachel J. Johnson,et al.  Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study , 2010, The Lancet.

[26]  P. Ponikowski,et al.  Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. , 2010, The New England journal of medicine.

[27]  T. V. van Veen,et al.  Selective deletion of Connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension. , 2010, Kidney international.

[28]  O. Celhay,et al.  Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy , 2010, Transplantation.

[29]  W. Irish,et al.  Cold Machine Perfusion or Static Cold Storage of Kidneys: Why the Debate Continues , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  K. Safranow,et al.  The association between eNOS intron 4 VNTR polymorphism and delayed graft function of kidney allografts , 2010, Clinical transplantation.

[31]  J. Bradley,et al.  Cold Machine Perfusion Versus Static Cold Storage of Kidneys Donated After Cardiac Death: A UK Multicenter Randomized Controlled Trial , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  M. Souter,et al.  Ethical controversies at end of life after traumatic brain injury: defining death and organ donation. , 2010, Critical care medicine.

[33]  Jeremiah R. Brown,et al.  Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  José A Fernández,et al.  Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. , 2010, The Journal of clinical investigation.

[35]  J. Iacomini,et al.  Identification of a microRNA signature of renal ischemia reperfusion injury , 2010, Proceedings of the National Academy of Sciences.

[36]  L. Rostaing,et al.  High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  P. Zhou,et al.  Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis. , 2010, Transplantation proceedings.

[38]  R. Bartlett,et al.  Extracorporeal Support: Improves Donor Renal Graft Function After Cardiac Death , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  T. Minor,et al.  Hypothermic reconditioning after cold storage improves postischemic graft function in isolated porcine kidneys , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[40]  M. Okusa,et al.  Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. , 2010, Seminars in nephrology.

[41]  A. Ismael,et al.  The Impact of Timing of Maximal Crystalloid Hydration on Early Graft Function During Kidney Transplantation , 2010, Anesthesia and analgesia.

[42]  R. Colvin,et al.  Tubular expression of KIM-1 does not predict delayed function after transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[43]  S. Feng,et al.  Diabetes Mellitus: A Risk Factor for Delayed Graft Function after Deceased Donor Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  J. Anderson,et al.  RGS4 Controls Renal Blood Flow and Inhibits Cyclosporine‐Mediated Nephrotoxicity , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[45]  N. Gretz,et al.  A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage. , 2010, Molecular immunology.

[46]  R. Goldschmeding,et al.  Histological assessment of pre‐transplant kidney biopsies is reproducible and representative , 2010, Histopathology.

[47]  L. Lerman,et al.  Anti‐thrombin Therapy During Warm Ischemia and Cold Preservation Prevents Chronic Kidney Graft Fibrosis in a DCD Model , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  T. Pruett Effects of Donor Pretreatment With Dopamine on Graft Function After Kidney Transplantation: A Randomized Controlled Trial , 2010 .

[49]  C. Cardella,et al.  Delayed graft function and the risk for death with a functioning graft. , 2010, Journal of the American Society of Nephrology : JASN.

[50]  C. Parikh,et al.  IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[51]  Gerhard Opelz,et al.  C3 polymorphisms and allograft outcome in renal transplantation. , 2009, The New England journal of medicine.

[52]  W. Winkelmayer,et al.  Effect of Hemodialysis Before Transplant Surgery on Renal Allograft Function—A Pair of Randomized Controlled Trials , 2009, Transplantation.

[53]  K. Budde,et al.  A Randomized Trial Comparing Renal Function in Older Kidney Transplant Patients Following Delayed Versus Immediate Tacrolimus Administration , 2009, Transplantation.

[54]  S. Ricardo,et al.  Renal primary cilia lengthen after acute tubular necrosis. , 2009, Journal of the American Society of Nephrology : JASN.

[55]  J. Czerwiński,et al.  Complications of transplantation of kidneys from expanded-criteria donors. , 2009, Transplantation proceedings.

[56]  N. Gretz,et al.  Wnt Pathway Regulation in Chronic Renal Allograft Damage , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[57]  R. Stratta,et al.  A Randomized Trial of Alemtuzumab Versus Antithymocyte Globulin Induction in Renal and Pancreas Transplantation , 2009, Transplantation.

[58]  A. Borobia,et al.  Trough Tacrolimus Concentrations in the First Week After Kidney Transplantation Are Related to Acute Rejection , 2009, Therapeutic drug monitoring.

[59]  P. Halloran,et al.  Diagnosing Rejection in Renal Transplants: A Comparison of Molecular‐ and Histopathology‐Based Approaches , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[60]  F. Thévenod,et al.  Iron transport and the kidney. , 2009, Biochimica et biophysica acta.

[61]  H. Rabb,et al.  The interaction between ischemia–reperfusion and immune responses in the kidney , 2009, Journal of Molecular Medicine.

[62]  A. Israni,et al.  Similar Outcomes with Different Rates of Delayed Graft Function May Reflect Center Practice, Not Center Performance , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[63]  J. Squifflet,et al.  Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. , 2009, Journal of the American Society of Nephrology : JASN.

[64]  L. Wrenshall,et al.  Increased Primary Non‐Function in Transplanted Deceased‐Donor Kidneys Flushed with Histidine‐Tryptophan‐Ketoglutarate Solution , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[65]  U. Völker,et al.  Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function , 2009, Pharmacogenetics and genomics.

[66]  Youhua Liu,et al.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis. , 2009, Journal of the American Society of Nephrology : JASN.

[67]  R. Formica,et al.  Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[68]  M. Givertz,et al.  Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure. , 2009, Expert opinion on pharmacotherapy.

[69]  M. Stegall,et al.  Pulmonary Hypertension Is Associated With Reduced Patient Survival After Kidney Transplantation , 2008, Transplantation.

[70]  A. Salim,et al.  Aggressive Organ Donor Management Protocol , 2008, Journal of intensive care medicine.

[71]  M. Christiaans,et al.  Histological Assessment of Preimplantation Biopsies May Improve Selection of Kidneys from Old Donors After Cardiac Death , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[72]  A. Garg,et al.  Marked variation in the definition and diagnosis of delayed graft function: a systematic review. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  A. Israni,et al.  Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  J. Gaynor,et al.  Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up , 2008, Transplantation.

[75]  S. Knechtle,et al.  Calcineurin Inhibitor Withdrawal After Renal Transplantation with Alemtuzumab: Clinical Outcomes and Effect on T‐Regulatory Cells , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[76]  J Concato,et al.  Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. , 2008, Kidney international.

[77]  V. Haase,et al.  Low oxygen stimulates the immune system. , 2008, Kidney international.

[78]  M. Hensel,et al.  Hypoxia and Hypoxia-Inducible Factor-1α Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function1 , 2008, The Journal of Immunology.

[79]  K. Salmela,et al.  Intragraft Coagulation Events and Delayed Graft Function in Clinical Renal Transplantation , 2008, Transplantation.

[80]  Joseph A. Cruz,et al.  The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[81]  J. Gaynor,et al.  A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow‐up , 2007, Clinical transplantation.

[82]  B. Gerstmayer,et al.  Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. , 2007, Antioxidants & redox signaling.

[83]  M. Żukowski,et al.  Influence of selected factors on occurrence of delayed kidney graft function: a multivariate analysis. , 2007, Transplantation proceedings.

[84]  P. Heeger,et al.  Graft-derived complement as a mediator of transplant injury. , 2007, Current opinion in immunology.

[85]  S. Chadban,et al.  TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.

[86]  E. Porrini,et al.  Randomized Controlled Study Comparing Reduced Calcineurin Inhibitors Exposure Versus Standard Cyclosporine-Based Immunosuppression , 2007, Transplantation.

[87]  A. Khanafer,et al.  Increased Nitric Oxide Production During Acute Rejection in Kidney Transplantation: A Useful Marker to Aid in the Diagnosis of Rejection , 2007, Transplantation.

[88]  G. Russ,et al.  Trends in Kidney Transplantation in Australia and New Zealand, 1993–2004 , 2007, Transplantation.

[89]  Claude D Martin,et al.  Impact of intensive care on renal function before graft harvest: results of a monocentric study , 2007, Critical care.

[90]  R. Bertini,et al.  Protective effect of an inhibitor of interleukin-8 (meraxin) from ischemia and reperfusion injury in a rat model of kidney transplantation. , 2007, Transplantation proceedings.

[91]  D. Villers,et al.  Effect of Brain-Dead Donor Resuscitation on Delayed Graft Function: Results of a Monocentric Analysis , 2007, Transplantation.

[92]  U. Hopt,et al.  Evaluation of preservation solutions by ESR-spectroscopy: superior effects of University of Wisconsin over Histidine-Tryptophan-Ketoglutarate in reducing renal reactive oxygen species. , 2007, Kidney international.

[93]  W. Buurman,et al.  Recipient Hemodynamics During Non‐Heart‐Beating Donor Kidney Transplantation Are Major Predictors of Primary Nonfunction , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[94]  K. Nath,et al.  Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. , 2007, Kidney international.

[95]  R. Quigg,et al.  Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. , 2007, Journal of the American Society of Nephrology : JASN.

[96]  T. Ganz Molecular control of iron transport. , 2007, Journal of the American Society of Nephrology : JASN.

[97]  B. Jaber,et al.  NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. , 2007, Journal of the American Society of Nephrology : JASN.

[98]  D. Brennan,et al.  Rabbit antithymocyte globulin versus basiliximab in renal transplantation. , 2006, The New England journal of medicine.

[99]  D. Pittrow,et al.  Role of endothelin and endothelin receptor antagonists in renal disease , 2006, European journal of clinical investigation.

[100]  R. Fisher,et al.  Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results. , 2006, Transplantation proceedings.

[101]  P. Devarajan Update on mechanisms of ischemic acute kidney injury. , 2006, Journal of the American Society of Nephrology : JASN.

[102]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[103]  L. Rostaing,et al.  Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[104]  A. Agarwal,et al.  Comparison of Histidine-Tryptophan Ketoglutarate Solution and University of Wisconsin Solution in Prolonged Cold Preservation of Kidney Allografts , 2006, Transplantation.

[105]  W. van Biesen,et al.  The impact of the pre-transplant renal replacement modality on outcome after cadaveric kidney transplantation: the ghent experience. , 2006, Contributions to nephrology.

[106]  P. Macdonald,et al.  Organ preservation. , 2006, Methods in molecular biology.

[107]  M. Stegall,et al.  Improving the Prediction of Donor Kidney Quality: Deceased Donor Score and Resistive Indices , 2005, Transplantation.

[108]  T. Minor,et al.  Oxygenated machine perfusion preservation of predamaged kidneys with HTK and Belzer machine perfusion solution: an experimental study in pigs. , 2005, Transplantation Proceedings.

[109]  D. Machin,et al.  Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1 , 2005, Transplantation.

[110]  J. Gaynor,et al.  A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1 , 2005, Transplantation.

[111]  Daniel C. Brennan,et al.  A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients , 2005, Transplantation.

[112]  Po-Huang Lee,et al.  Expanding the donor pool: use of renal transplants from non‐heart‐beating donors supported with extracorporeal membrane oxygenation , 2005, Clinical transplantation.

[113]  G. Remuzzi,et al.  Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. , 2005, Kidney international.

[114]  A. Kandus,et al.  Prevention of Early Acute Rejection With Daclizumab and Triple Immunosuppression in Cadaveric Renal Allograft Recipients , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[115]  R. Bartlett,et al.  Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. , 2004, The Journal of trauma.

[116]  B. Korf,et al.  PERFUSION PARAMETERS IN PREDICTING OUTCOMES OF MACHINE PRESERVED KIDNEYS , 2004 .

[117]  K. Voigt,et al.  Hemodynamic responses to noxious stimuli in brain-dead organ donors , 2005, Intensive Care Medicine.

[118]  R. Vanholder,et al.  Delayed graft function in renal transplantation , 2004, Current opinion in critical care.

[119]  D. Stolz,et al.  Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. , 2004, American journal of physiology. Renal physiology.

[120]  K. Budde,et al.  Calcium Channel Blockade and Preservation of Renal Graft Function in Cyclosporine-Treated Recipients: A Prospective Randomized Placebo-Controlled 2-Year Study , 2004, Transplantation.

[121]  Y. Becker,et al.  Campath-1H in renal transplantation: The University of Wisconsin experience. , 2004, Surgery.

[122]  M. Schnitzler,et al.  Five-Year Follow Up of Thymoglobulin Versus ATGAM Induction in Adult Renal Transplantation , 2004, Transplantation.

[123]  C. Szabó,et al.  Poly(ADP-ribose) polymerase and renal hypothermic preservation injury. , 2004, American journal of physiology. Renal physiology.

[124]  H. Anders,et al.  Signaling danger: toll-like receptors and their potential roles in kidney disease. , 2004, Journal of the American Society of Nephrology : JASN.

[125]  B. Aizenstein,et al.  Elevation of CXCR3‐Binding Chemokines in Urine Indicates Acute Renal‐Allograft Dysfunction , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[126]  S. Post,et al.  Impact of Donor Dopamine on Immediate Graft Function after Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[127]  A. Yim,et al.  Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyperpolarizing factor-mediated function during heart preservation: comparison with University of Wisconsin solution. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[128]  J. Punch,et al.  Kidney transplantation from organ donors following cardiopulmonary death using extracorporeal membrane oxygenation support. , 2004, Annals of transplantation.

[129]  M. Radomski,et al.  The Nitric Oxide-Endothelin-1 Connection , 2004, Heart Failure Reviews.

[130]  V. Papadopoulos,et al.  Evidence for a protective role of trimetazidine during cold ischemia: targeting inflammation and nephron mass. , 2003, Biochemical pharmacology.

[131]  G. Molema,et al.  Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. , 2003, Kidney international.

[132]  K. Matsushima,et al.  J Am Soc Nephrol 14: 2503–2515, 2003 CCR2 Signaling Contributes to Ischemia-Reperfusion Injury , 2022 .

[133]  J. Chilcott,et al.  Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review , 2003, Clinical transplantation.

[134]  M. Sarwal,et al.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.

[135]  J. Antonelli,et al.  Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats1 , 2003, Transplantation.

[136]  N. Patel,et al.  GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. , 2003, Kidney international.

[137]  F. Delmonico,et al.  Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.

[138]  F. Delmonico,et al.  A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients , 2003 .

[139]  Christopher P. Johnson,et al.  Post-transplant renal function in the first year predicts long-term kidney transplant survival. , 2002, Kidney international.

[140]  R. Loutzenhiser,et al.  Renal Myogenic Response: Kinetic Attributes and Physiological Role , 2002, Circulation research.

[141]  S. Sacks,et al.  Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.

[142]  P. Friend,et al.  Liver and kidney preservation by perfusion , 2002, The Lancet.

[143]  J. Alexander,et al.  Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. , 2002, American journal of physiology. Renal physiology.

[144]  H. Meier‐Kriesche,et al.  The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. , 2002, Transplantation.

[145]  O. Toupance,et al.  Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF‐containing Triple Therapy , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[146]  M. Pescovitz,et al.  BASILIXIMAB VERSUS ANTITHYMOCYTE GLOBULIN FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1,2 , 2001, Transplantation.

[147]  D. Shoskes,et al.  Delayed graft function: Influence on outcome and strategies for prevention , 2001 .

[148]  J. Squifflet,et al.  INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 2001, Transplantation.

[149]  M. Pescovitz,et al.  Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. , 2001, Transplantation.

[150]  T. Larson,et al.  Donor Scoring System for Cadaveric Renal Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[151]  J. Lácha,et al.  Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients. , 2001, Transplantation proceedings.

[152]  H. Rabb,et al.  Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. , 2000, American journal of physiology. Renal physiology.

[153]  H. Iwamoto,et al.  Prediction of kidney nonfunction after transplantation with machine perfusion preservation. , 2000, Transplantation proceedings.

[154]  K. Kubota,et al.  A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors. , 2000, Transplantation proceedings.

[155]  K. Ley,et al.  Blocking P‐selectin protects from ischemia/reperfusion‐induced acute renal failure , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[156]  A. Novick,et al.  A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants. , 1999, Transplantation.

[157]  I. Doxiadis,et al.  Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins , 1999, Transplant international : official journal of the European Society for Organ Transplantation.

[158]  S. Fuggle,et al.  Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. , 1999, Kidney international.

[159]  D. Jeyarajah,et al.  Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? , 1999, Kidney international.

[160]  J Karpinski,et al.  Outcome of kidney transplantation from high-risk donors is determined by both structure and function. , 1999, Transplantation.

[161]  M. Schnitzler,et al.  A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. , 1999, Transplantation.

[162]  E. Condom,et al.  Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[163]  K. Salmela,et al.  A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. , 1999, Transplantation.

[164]  W. Jassem,et al.  Delayed graft function: risk factors and the relative effects of early function and acute rejection on long‐term survival in cadaveric renal transplantation , 1999, Clinical transplantation.

[165]  B. Maes,et al.  Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. , 1998, Transplantation.

[166]  D. Shoskes,et al.  Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. , 1998 .

[167]  S. Fuggle,et al.  Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. , 1998, The American journal of pathology.

[168]  D. Pinsky,et al.  Hypoxia-mediated modulation of vascular function--implications for organ preservation and thrombogenesis: Roger S. Mitchell lecture. , 1998, Chest.

[169]  F. Vermassen,et al.  Pretransplantation hemodialysis strategy influences early renal graft function. , 1998, Journal of the American Society of Nephrology : JASN.

[170]  J Neylan,et al.  Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. , 1998, The New England journal of medicine.

[171]  A. Matas,et al.  Effect of initial slow graft function on renal allograft rejection and survival. , 1997, Clinical transplantation.

[172]  J. H. van Bockel,et al.  Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. , 1997, Transplantation.

[173]  R. Wolfe,et al.  Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.

[174]  D. Shoskes,et al.  Effect of delayed graft function on short- and long-term kidney graft survival. , 1997, Clinical transplants.

[175]  D. Klassen,et al.  Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience. , 1996, Clinical transplantation.

[176]  P. Halloran,et al.  Delayed graft function in renal transplantation: etiology, management and long-term significance. , 1996, The Journal of urology.

[177]  H. Friess,et al.  Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4. , 1996, Transplantation proceedings.

[178]  P. Halloran,et al.  Acute Renal Injury In The Interferon-γ Gene Knockout Mouse: Effect On Cytokine Gene Expression1 , 1995 .

[179]  P. Halloran,et al.  Acute renal injury in the interferon-gamma gene knockout mouse: effect on cytokine gene expression. , 1995, Transplantation.

[180]  R. Hetzer,et al.  Myocardial preservation using HTK solution for heart transplantation. A multicenter study. , 1993, European Journal of Cardio-Thoracic Surgery.

[181]  A. Hendrich,et al.  Changes in serum catecholamine levels in patients who are brain dead. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[182]  U. Kunzendorf,et al.  Protective effects of calcium antagonists in human renal transplantation. , 1992, Kidney international. Supplement.

[183]  J. Robinette,et al.  Differences in vascular reactivity in models of ischemic acute renal failure. , 1991, Kidney international.

[184]  R. Miller,et al.  Effect of recovery from ischemic injury on class I and class II MHC antigen expression. , 1990, Transplantation.

[185]  W. Raub From the National Institutes of Health. , 1990, JAMA.

[186]  P. Halloran,et al.  Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. , 1990, Transplantation.

[187]  M. Giral,et al.  Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin. , 1989, Transplantation proceedings.

[188]  V. Farewell,et al.  Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. , 1989, Transplantation.

[189]  R. Ploeg,et al.  SUCCESSFUL 72‐HOUR COLD STORAGE OF DOG KIDNEYS WITH UW SOLUTION , 1988, Transplantation.

[190]  J H Southard,et al.  Principles of solid-organ preservation by cold storage. , 1988, Transplantation.

[191]  W. Waltzer,et al.  The pathophysiology of the no-reflow phenomenon in cold-stored kidneys. , 1987, Transplantation proceedings.

[192]  J H Southard,et al.  Development of a cold storage solution for pancreas preservation. , 1986, Cryobiology.

[193]  A. Novick,et al.  DETRIMENTAL EFFECT OF CYCLOSPORINE ON INITIAL FUNCTION OF CADAVER RENAL ALLOGRAFTS FOLLOWING EXTENDED PRESERVATION Results of a randomized Prospective Study , 1986, Transplantation.

[194]  P. W. Hochachka Defense strategies against hypoxia and hypothermia. , 1986, Science.

[195]  Lond Mb Frederick Ronald Chistopher Casson. , 1975 .

[196]  P. Terasaki,et al.  Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. , 1970, Lancet.

[197]  M. Kowada,et al.  Cerebral ischemia. II. The no-reflow phenomenon. , 1968, The American journal of pathology.